“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about OmniaBio
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world
| C-Level 3 | VP - Level2 |
| Director14 | Manager26 |
| Others41 | |
| Structure | Email Format |
|---|---|
| <first>.<last>@ | John.Smith@omniabio.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Artificial Intelligence | Toronto, Ontario, Canada | accessibility, compliance, collaboration, protection, gmp |
| Automation Testing | Toronto, Ontario, Canada | accessibility, compliance, collaboration, protection, gmp |
| Build & Release | Toronto, Ontario, Canada | accessibility, compliance, collaboration, protection, gmp |
| Compliance | Toronto, Ontario, Canada | accessibility, compliance, collaboration, protection, gmp |
| Digital Transformation | Toronto, Ontario, Canada | accessibility, compliance, collaboration, protection, gmp |
OmniaBio looking to hire in Application Development in Toronto, Ontario, Canada
OmniaBio looking to hire in Artificial Intelligence in Hamilton, Ontario, Canada
OmniaBio looking to hire in Artificial Intelligence in Toronto, Ontario, Canada
Amazon connect
Cmms
Gcp
Access
Aws
Agile
Accessibility
Assessment
Audit
Calibration
DescriptionPosition at OmniaBioPosition OverviewThe Business Leader & CMC Advisor, Autologous The...
View MoreOmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world
Omniabio operates in the Biotechnology research industry.
Omniabio's revenue is $5.50m
Omniabio has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.